Annual report pursuant to Section 13 and 15(d)

Earnings Per Share (Tables)

v3.22.4
Earnings Per Share (Tables)
12 Months Ended
Dec. 31, 2022
Earnings Per Share [Abstract]  
Schedule of Basic and Diluted Earnings Per Share

Shares used in the computation of the Company’s basic and diluted earnings per share are as follows:

(in thousands, except per share data)

 

Year Ended December 31,

 

 

 

2022

 

 

2021

 

 

2020

 

Numerator

 

 

 

 

 

 

 

 

 

Net increase (decrease) in net assets resulting from operations

 

$

102,081

 

 

$

174,155

 

 

$

227,261

 

Less: Total distributions declared

 

 

(249,077

)

 

 

(179,575

)

 

 

(155,761

)

Total Earnings, net of total distributions

 

 

(146,996

)

 

 

(5,420

)

 

 

71,500

 

 

 

 

 

 

 

 

 

 

 

Earnings, net of distributions attributable to common shares

 

 

(146,995

)

 

 

(5,420

)

 

 

70,995

 

Add: Distributions declared attributable to common shares

 

 

246,873

 

 

 

177,864

 

 

 

154,658

 

Numerator for basic and diluted change in net assets per common share

 

$

99,878

 

 

$

172,444

 

 

$

225,653

 

 

 

 

 

 

 

 

 

 

 

Denominator

 

 

 

 

 

 

 

 

 

Basic weighted average common shares outstanding

 

 

125,189

 

 

 

114,742

 

 

 

111,985

 

Incremental shares from assumed conversion of 2022 Convertible Notes

 

 

—

 

 

 

512

 

 

 

—

 

Common shares issuable

 

 

1,470

 

 

 

701

 

 

 

282

 

Weighted average common shares outstanding assuming dilution

 

 

126,659

 

 

 

115,955

 

 

 

112,267

 

 

 

 

 

 

 

 

 

 

 

Change in net assets per common share:

 

 

 

 

 

 

 

 

 

Basic

 

$

0.80

 

 

$

1.50

 

 

$

2.02

 

Diluted

 

$

0.79

 

 

$

1.49

 

 

$

2.01

 

Schedule of Number of Anti-diluted Shares As Calculated Based on Weighted Average Closing Price of Common Stock For the years ended December 31, 2022, 2021 and 2020, the number of anti-dilutive shares, as calculated based on the weighted average closing price of the Company’s common stock for the periods, are as follows:

 

 

Year Ended December 31,

 

Anti-dilutive Securities

 

2022

 

 

2021

 

 

2020

 

2022 Convertible Notes

 

 

—

 

 

 

—

 

 

 

5,543,097

 

Unvested common stock options

 

 

2,085

 

 

 

690

 

 

 

66,578

 

Restricted stock units*

 

 

—

 

 

 

20

 

 

 

—

 

Unvested restricted stock awards

 

 

2,116

 

 

 

861

 

 

 

10,049

 

Performance awards*

 

 

—

 

 

 

—

 

 

 

—